JPS5829317B2 - １５ アルフア− １６ アルフア− − メチレン −４− エストレン −１７ ベ−タ − オ−ルノセイホウ - Google Patents

１５ アルフア− １６ アルフア− − メチレン −４− エストレン −１７ ベ−タ − オ−ルノセイホウ

Info

Publication number
JPS5829317B2
JPS5829317B2 JP48017357A JP1735773A JPS5829317B2 JP S5829317 B2 JPS5829317 B2 JP S5829317B2 JP 48017357 A JP48017357 A JP 48017357A JP 1735773 A JP1735773 A JP 1735773A JP S5829317 B2 JPS5829317 B2 JP S5829317B2
Authority
JP
Japan
Prior art keywords
methylene
methyl
dimethyl
ethynyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48017357A
Other languages
English (en)
Japanese (ja)
Other versions
JPS4886856A (ro
Inventor
シユタインベツク ヘルマン
ヴイーヒエルト ルードルフ
エルゲル ヴアルター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS4886856A publication Critical patent/JPS4886856A/ja
Publication of JPS5829317B2 publication Critical patent/JPS5829317B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP48017357A 1972-02-11 1973-02-12 １５ アルフア− １６ アルフア− − メチレン −４− エストレン −１７ ベ−タ − オ−ルノセイホウ Expired JPS5829317B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
JPS4886856A JPS4886856A (ro) 1973-11-15
JPS5829317B2 true JPS5829317B2 (ja) 1983-06-22

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48017357A Expired JPS5829317B2 (ja) 1972-02-11 1973-02-12 １５ アルフア− １６ アルフア− − メチレン −４− エストレン −１７ ベ−タ − オ−ルノセイホウ

Country Status (29)

Country Link
JP (1) JPS5829317B2 (ro)
KR (1) KR780000156B1 (ro)
AT (1) AT327413B (ro)
AU (1) AU467306B2 (ro)
BE (1) BE795241A (ro)
CA (1) CA997753A (ro)
CH (2) CH590883A5 (ro)
CS (1) CS193019B2 (ro)
DD (1) DD102379A5 (ro)
DE (1) DE2207421C3 (ro)
DK (1) DK131037B (ro)
EG (1) EG10914A (ro)
ES (1) ES410933A1 (ro)
FI (1) FI52225C (ro)
FR (1) FR2181719B1 (ro)
GB (1) GB1425636A (ro)
GR (1) GR63160B (ro)
HU (1) HU165253B (ro)
IE (1) IE37266B1 (ro)
IL (1) IL41506A (ro)
NL (1) NL177217C (ro)
NO (2) NO140304C (ro)
PH (1) PH9370A (ro)
PL (1) PL81084B1 (ro)
RO (1) RO73527A (ro)
SE (3) SE403781B (ro)
SU (1) SU513628A3 (ro)
YU (1) YU35035B (ro)
ZA (1) ZA73944B (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
ATA112473A (de) 1975-04-15
CA997753A (en) 1976-09-28
DK131037B (da) 1975-05-20
DE2207421A1 (de) 1973-08-16
KR780000156B1 (en) 1978-05-02
NO143065B (no) 1980-09-01
AU5207673A (en) 1974-08-15
DE2207421B2 (de) 1980-07-24
ZA73944B (en) 1973-11-28
CH593995A5 (ro) 1977-12-30
GB1425636A (en) 1976-02-18
NO143065C (no) 1980-12-10
DD102379A5 (ro) 1973-12-12
GR63160B (en) 1979-09-25
PH9370A (en) 1975-10-22
NL177217C (nl) 1985-08-16
CH590883A5 (ro) 1977-08-31
IL41506A0 (en) 1973-04-30
SU513628A3 (ru) 1976-05-05
EG10914A (en) 1976-09-30
SE7713896L (sv) 1977-12-07
SE426834B (sv) 1983-02-14
DK131037C (ro) 1975-10-20
BE795241A (fr) 1973-08-09
CS193019B2 (en) 1979-09-17
IL41506A (en) 1976-07-30
NL177217B (nl) 1985-03-18
JPS4886856A (ro) 1973-11-15
NL7301974A (ro) 1973-08-14
NO140304B (no) 1979-04-30
ES410933A1 (es) 1976-03-01
IE37266L (en) 1973-08-11
FR2181719B1 (ro) 1975-11-21
NO782754L (no) 1973-08-14
FI52225C (fi) 1977-07-11
RO73527A (ro) 1982-02-01
FI52225B (ro) 1977-03-31
PL81084B1 (ro) 1975-08-30
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
YU35035B (en) 1980-06-30
DE2207421C3 (de) 1981-05-07
SE409329B (sv) 1979-08-13
HU165253B (ro) 1974-07-27
SE7514513L (sv) 1975-12-22
IE37266B1 (en) 1977-06-08
FR2181719A1 (ro) 1973-12-07
YU24373A (en) 1979-12-31
AT327413B (de) 1976-01-26
AU467306B2 (en) 1975-11-27

Similar Documents

Publication Publication Date Title
US3580937A (en) 7alpha- and 7beta-methyl-3alpha,5alpha-cycloandrostanes,6-methyl derivatives thereof and the 19-nor analogues of the foregoing
JPS6069096A (ja) 新規ステロイド
PT1272504E (pt) Estratrienos com uma substituição 8b-carbonilo como estrogénios com actividade selectiva
JP2768707B2 (ja) 新規の１１−アリールステロイド化合物
Peters et al. 17-Desoxy estrogen analogs
US3159543A (en) 3-cyclopentyl and cyclopentenyl ethers of estrone and derivatives thereof
US3445489A (en) 9beta,10alpha-steroids,intermediates therefor and pharmaceutical preparations containing these compounds as an active ingredient
JPH0564639B2 (ro)
US3407217A (en) 8-iso-13-polycarbonalkyl gonanes
US3951958A (en) 1,3-Oxygenated-8α-estratrienes
US3960841A (en) 3,17,18-Trihydroxy-1,3,5(10)-estratrienes
US3951959A (en) 1,3-Oxygenated 8α-estratrienes
JPS5829317B2 (ja) １５ アルフア− １６ アルフア− − メチレン −４− エストレン −１７ ベ−タ − オ−ルノセイホウ
US3436390A (en) 4,4-dihydroxy-2-butenoic acid lactones
US3875188A (en) 17-Beta-alpha-lower alkyl allene-substituted steroids
US3574197A (en) Process of producing 1-hydroxy-7alpha-methyl-estradiol derivatives
JP4749550B2 (ja) アンドロゲンとしての１４β，１７α−ヒドロキシメチルアンドロスタン誘導体
US3709878A (en) 8 alpha-methyl-substituted-steroids
US3749742A (en) 15alpha,16alpha-methylene steroids and processes for their production and use
US3461118A (en) 3beta-tetrahydrofuranyloxy - and 3beta-tetrahydropyranyloxyestra - 4,9(10) - dienes and -4,9(10),11-trienes,their preparation and intermediates thereof
JPS6321680B2 (ro)
US4390530A (en) 3-Deoxy-Δ15 -steroids
US3470159A (en) Estra-1,3,5(10),7-tetraenes and process of preparation
US3994937A (en) 15α,16α-Methylene-4-estren-17β-ols
US3465011A (en) 11-oxygenated-8-iso steroids